Perth, March 9: Australia will gain access to one of the world’s most advanced comprehensive health and longevity tests following a new partnership between healthcare technology company TMRW and US-based epigenetic testing firm TruDiagnostic.
The collaboration brings TruDiagnostic’s biological age and health analysis technology to Australia for the first time through TMRW’s personalised health platform, which combines laboratory testing, artificial intelligence and medical data to provide a detailed picture of long-term health.
TruDiagnostic’s testing has been used internationally by doctors, researchers and high-profile figures in the health and wellness industry, including entrepreneur Bryan Johnson as part of his Blueprint longevity program. The technology has also featured in popular media, including an episode of The Kardashians, where biological age testing was explored as part of the growing interest in personalised health monitoring.
The process begins with a finger-prick blood sample taken at home, which is analysed at TruDiagnostic’s laboratory in Kentucky, United States. Results are then combined with personal health history and lifestyle information to generate a detailed report covering areas such as metabolism, immune function, hormone balance, cardiovascular health and cognitive performance.
TMRW says the system is designed to move beyond traditional health checks by identifying early indicators of ageing and disease risk before symptoms appear.
Mark Britt, founder and chief executive of TMRW, said the partnership aims to make advanced health data more accessible to Australians.
“We want people to live better and longer, not just add years to life but improve the quality of those years. By combining epigenetic testing with artificial intelligence and clinical data, we can give individuals a clearer understanding of their health and what they can do to improve it,” he said.
TruDiagnostic chief executive Dr Matt Dawson said the collaboration represents one of the most comprehensive integrations of epigenetic testing technology outside the United States.
Until now, Australians seeking this type of analysis often had to send samples overseas without local medical support. Under the new arrangement, testing will be offered through TMRW’s program with GP referrals and personalised health guidance.
The launch reflects growing global interest in longevity science, personalised medicine and biological age testing, as more consumers seek ways to monitor health and prevent disease rather than treat it after symptoms appear.
TMRW said more than 500 people have already joined the waitlist ahead of the Australian rollout.
Media & PR: editor@dailystraits.com. Copyright 2021–Present DailyStraits.com. All rights reserved.